Skip to main content
. 2020 Oct 22;9(11):347. doi: 10.3390/biology9110347

Figure 3.

Figure 3

EMPA ameliorates neuropathy and retinopathy in T1D but not T2D mouse models. (A–D) Terminal sensory nerve conduction velocity (NCV) (A), motor NCV (B), intraepidermal nerve fiber density (IENFD) (C), and terminal retinal apoptosis (D) in T1D (db/+ STZ), T2D (db/db), and control (db/+) mice with/without EMPA; n = 4–10 mice per group; * p < 0.05, *** p < 0.001 for untreated control vs. untreated T1D or T2D; ## p < 0.01, ### p < 0.001 for untreated vs. treated T1D; by one-way ANOVA. Data are expressed as the mean ± s.e.m.